Roivant Sciences (ROIV) Cash Flow: Operating & Free Cash Flow

Roivant Sciences Cash Flow Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Roivant Sciences Ltd. (ROIV) - Annual data in billions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Operating Activities
Net Income	-0.40	-0.36	4.23	-1.12	-0.92	-0.90	-0.52
Depreciation & Amortization	0.00	0.01	0.02	0.02	0.01	0.00	0.00
Stock Based Compensation	0.35	0.29	0.20	0.22	0.56	0.08	0.00
Change in Working Capital	-0.62	-0.08	0.02	0.01	0.02	0.11	0.02
Change in Accounts Receivable	-0.77	0.00	0.00	0.00	0.00	0.00	0.00
Change in Accounts Payable	0.00	-0.02	0.02	0.00	0.02	0.00	0.01
Change in Other Working Capital	-0.77	-0.04	-0.08	-0.06	0.00	0.06	0.01
Other Operating Activities	-0.08	-0.71	-5.24	0.03	-0.34	0.19	-0.26
Net Cash from Operating Activities	-0.75	-0.84	-0.77	-0.84	-0.68	-0.55	-0.76
Investing Activities
Capital Expenditures	-0.01	0.00	0.00	-0.01	-0.02	-0.01	0.00
Acquisitions	0.00	-0.03	-0.08	-0.01	0.00	0.00	1.77
Purchases of Investments	0.00	-4.06	0.00	0.00	0.00	0.00	-0.07
Sales/Maturities of Investments	4.13	1.96	0.00	0.11	0.32	0.00	0.02
Other Investing Activities	-0.01	-0.03	-0.08	-0.15	0.00	-0.03	-0.02
Net Cash from Investing Activities	-0.68	-1.77	5.20	-0.04	0.30	-0.03	1.69
Financing Activities
Debt Repayment	0.00	-0.05	-0.03	-0.03	0.01	0.00	-0.03
Common Stock Issued	0.27	0.05	0.26	0.32	0.10	0.46	1.35
Common Stock Repurchased	-0.37	-1.33	-0.04	-0.01	0.00	0.00	-1.19
Dividends Paid	0.00	0.00	-0.01	0.00	0.00	0.00	0.00
Other Financing Activities	0.23	0.11	0.23	0.07	0.19	0.46	0.08
Net Cash from Financing Activities	0.13	-1.22	0.42	0.50	0.31	0.46	0.22
Summary
Effect of Forex Changes on Cash	0.00	0.00	0.00	0.01	0.00	0.00	0.19
Net Change in Cash	-1.29	-3.82	4.86	-0.38	-0.07	-0.13	1.34
Cash at Beginning of Period	2.73	6.55	1.69	2.07	2.13	2.27	0.85
Cash at End of Period	1.43	2.73	6.55	1.69	2.06	2.14	2.19
Free Cash Flow	-0.76	-0.84	-0.77	-0.86	-0.70	-0.56	-0.77
Supplemental Disclosures
Interest Paid	-	0.01	0.01	0.01	0.01	0.00	-
Income Taxes Paid	-	0.06	0.01	0.01	0.00	0.00	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Roivant Sciences Cash Flow

What is Roivant Sciences's free cash flow?

Roivant Sciences had negative free cash flow of $758.56M in fiscal 2026 (fiscal year ended Mar 31, 2026), operating cash flow of −$750.35M minus $8.21M of capital expenditures.

How much does Roivant Sciences spend on capital expenditures?

Roivant Sciences spent $8.21M on capital expenditures in fiscal 2026, compared with $4.60M a year earlier.

Does Roivant Sciences pay dividends or buy back shares?

Yes. In fiscal 2026 Roivant Sciences returned $366.72M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition